+1 862-686-2696
Featured Products
Primary Cells
Immortalized Cell Lines
Stem Cells
Tumor Cell Lines
Transfected Stable Cell Lines
Exosomes
MicroRNA Agomir/Antagomir
Cell Culture Media, Kits & Reagents
Explore Products
Cell
Cell
MicroRNA
MicroRNA
Test and Analysis
Test and Analysis
Primary Cells

Human Acute Myeloid Leukemia Bone Marrow-CD34+ Cells (Newly Diagnosed)

  • For research use only

Cat No.

ABC-TC3021
Product Type

Immune Cells
Cell Type

CD34+
Species

Human
Growth Conditions

37 ℃, 5% CO2
Source Organ

Bone Marrow
Disease

Acute Lymphoid Leukemia
Storage

Liquid Nitrogen

Human Acute Myeloid Leukemia Bone Marrow-CD34+ Cells (Newly Diagnosed) support leukemia modeling, immune profiling, and gene expression studies in AML.

Product Image
  • Human Acute Myeloid Leukemia Bone Marrow-CD34+ Cells (Newly Diagnosed)
Get a Quote
Home | Primary Cells | Human Primary Cells | Immune System Primary Cells | Human Acute Myeloid Leukemia Bone Marrow-CD34+ Cells (Newly Diagnosed)

Description

Human Acute Myeloid Leukemia (AML) Bone Marrow-CD34+ Cells (Newly Diagnosed) are primary hematopoietic progenitor cells isolated from the bone marrow of newly diagnosed AML patients. These CD34+ cells represent a malignant stem-like subpopulation with self-renewal potential and aberrant differentiation, closely related to the biology of leukemia stem cells CD34+, contributing to leukemogenesis. Morphologically, they grow in suspension. These cells often harbor cytogenetic abnormalities such as t(8;21), inv(16), or complex karyotypes, which are associated with distinct AML subtypes. These cells express CD34 and CD117, while lacking lineage-specific markers (CD3⁻, CD19⁻). Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

Human Acute Myeloid Leukemia Bone Marrow-CD34+ Cells (Newly Diagnosed), AML BM CD34+ ND, Human AML BM CD34+ cells
Species

Human
Cat.No

ABC-TC3021
Product Category

Primary Cells
Size/Quantity

1 vial
Cell Type

CD34+
Shipping Info

Dry Ice
Growth Conditions

37 ℃, 5% CO2
Source Organ

Bone Marrow
Disease

Acute Lymphoid Leukemia
Biosafety Level

1
Storage

Liquid Nitrogen
Product Type

Immune Cells
Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human AML Bone Marrow-CD34+ Cells are suitable for studying leukemic stem cell biology, drug resistance mechanisms, and response to targeted therapies such as FLT3 or BCL2 inhibitors. They provide a clinically relevant model for preclinical screening of anti-leukemic compounds and investigating minimal residual disease (MRD) in acute myeloid leukemia. They are also used in xenotransplantation models to evaluate leukemia-initiating potential and therapeutic efficacy in vivo.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

  • Online Inquiry
  • Product Reviews

Inquiring Human Acute Myeloid Leukemia Bone Marrow-CD34+ Cells (Newly Diagnosed)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

Let's Advance Life Science Research Together

Contact Us
AcceGen Scroll Top Button